Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 6;9(12):11130-11136.
doi: 10.1021/acscatal.9b03557. Epub 2019 Oct 29.

Cu-Catalyzed Hydroboration of Benzylidenecyclopropanes: Reaction Optimization, (Hetero)Aryl Scope, and Origins of Pathway Selectivity

Affiliations

Cu-Catalyzed Hydroboration of Benzylidenecyclopropanes: Reaction Optimization, (Hetero)Aryl Scope, and Origins of Pathway Selectivity

Jose M Medina et al. ACS Catal. .

Abstract

The copper-catalyzed hydroboration of benzylidenecyclopropanes, conveniently accessed in one step from readily available benzaldehydes, is reported. Under otherwise identical reaction conditions, two distinct phosphine ligands grant access to different products by either suppressing or promoting cyclopropane opening via β-carbon elimination. Computational studies provide insight into how the rigidity and steric environment of these different bis-phosphine ligands influence the relative activation energies of β-carbon elimination versus protodecupration from the key benzylcopper intermediate. The method tolerates a wide variety of heterocycles prevalent in clinical and pre-clinical drug development, giving access to valuable synthetic intermediates. The versatility of the tertiary cyclopropylboronic ester products is demonstrated through several derivatization reactions.

Keywords: Copper catalysis; benzylidenecyclopropanes; cyclopropylboronic esters; heterocycles; hydroborations; β-carbon elimination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1.
Figure 1.
Overview of Proposed Approach to Preparation of Cyclopropylboronic Esters.
Figure 2.
Figure 2.
Origin of ligand effects on β-carbon elimination and protodecupration barriers.
Scheme 1.
Scheme 1.. Hydroboration of BCPs with substituted arenes
aReaction conditions: 1 (0.2 mmol), CuCl (10 mol%), rac-BINAP (10 mol%), B2pin2 (0.3 mmol), NaOt-Bu (0.2 mmol), MeOH (0.2 mmol) in THF (0.5 mL) at room temperature. Percentages refer to the isolated yields. bThe values in parentheses correspond to NMR yields with (C6F5)3P as ligand in place of rac-BINAP
Scheme 2.
Scheme 2.. Hydroboration of BCPs with heterocycles
aReaction conditions: 1 (0.2 mmol), CuCl (10 mol%), rac-BINAP (10 mol%), B2pin2 (0.3 mmol), NaOt-Bu (0.2 mmol), MeOH (0.2 mmol) in THF (0.5 mL) at room temperature. Percentages refer to the isolated yields. b The values in parentheses correspond to NMR yields with (C6F5)3P as ligand in place of rac-BINAP. cYield determined by 1H NMR. The product was isolated as the corresponding BF3K salt in 51% yield over two steps.
Scheme 3.
Scheme 3.. Synthesis of alkenyl boronates via β-C elimination
aReaction conditions: 1 (0.2 mmol), CuCl (10 mol%), dppe (10 mol%), B2pin2 (0.3 mmol), NaOt-Bu (0.2 mmol), MeOH (0.2 mmol) in THF (0.5 mL) at room temperature. Percentages refer to the isolated yields.
Scheme 4.
Scheme 4.
Select derivatization reactions with tertiary boronic ester 3a
Scheme 5.
Scheme 5.
Enabling Suzuki–Miyaura couplings with tertiary trifluoroborate 8
Scheme 6.
Scheme 6.
Activation energies of the selectivity-determining steps.

References

    1. de Meijere A; Kozhushkov SI; Schill H Three-Membered-Ring-Based Molecular Architectures. Chem. Rev 2006, 106, 4926–4996. - PubMed
    2. Lovering F; Bikker J; Humblet C Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success. J. Med. Chem 2009, 52, 6752–6756. - PubMed
    3. Chen DY-K; Pouwer RH; Richard J-A Recent Advances in the Total Synthesis of Cyclopropane-Containing Natural Products. Chem. Soc. Rev 2012, 41, 4631–4642. - PubMed
    4. Taylor RD; MacCoss M; Lawson ADG Rings in Drugs. J. Med. Chem 2014, 57, 5845–5859. - PubMed
    1. Gagnon A; Duplessis M; Fader L Arylcyclopropanes: Properties, Synthesis and Use in Medicinal Chemistry. Org. Prep. Proced. Int 2010, 42, 1–69.
    2. Talele TT The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. J. Med. Chem 2016, 59, 8712–8756. - PubMed
    3. Derosa J; O’Duill ML; Holcomb M; Boulous MN; Patman RL; Wang F; Tran-Dube M; McAlpine I; Engle KM Copper-Catalyzed Chan−Lam Cyclopropylation of Phenols and Azaheterocycles. J. Org. Chem 2018, 83, 3417–3425. - PMC - PubMed
    1. Butcher KJ; Denton SM; Field SE; Gillmore AT; Harbottle GW; Howard RM; Laity DA; Ngono CJ; Pibworth BA Convergent Asymmetric Synthesis of Two Complex TRPV1 Antagonists. Org. Process Res. Dev 2011, 15, 1192–1200.
    1. Micheli F; Cavanni P; Andreotti D; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Carletti R; Checchia A; Corsi M; Fazzolari E; Fontana S; Marchioro C; Merlo-Pich E; Negri M; Oliosi B; Ratti E; Read KD; Roscic M; Sartori I; Spada S; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L; Di Fabio R 6-(3,4-Dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor. J. Med. Chem 2010, 53, 4989–5001. - PubMed
    1. Zillhardt M; Park S-M; Romero IL; Sawada K; Montag A; Krausz T; Yamada SD; Peter ME; Lengyel E Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis. Clin. Cancer Res 2011, 17, 4042–4051. - PMC - PubMed